Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Plerixafor

EU orphan designation number: EU/3/11/931   
Active ingredient: Plerixafor
Indication: Adjunctive treatment to cytotoxic therapy in acute myeloid leukaemia
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Centralised Orphan - Designation EMA/OD/074/11 (2011)9417 of 09/12/2011